Limit On Phytosterol CHD Health Claim Would Disrupt Industry – Cargill

Dietary supplement industry stakeholders "urgently" ask FDA to continue allowing coronary heart disease reduction health claims for supplements with nonesterified phytosterols, or risk "irreparable injury" to some firms.

More from Archive

More from Pink Sheet